logo
  

Stock Alert: Marinus Pharmaceuticals Down 14%

Shares of Marinus Pharmaceuticals Inc. (MRNS) are currently losing 14% Friday morning. The company announced a mixed shelf offering of up to $250 million.

MRNS is currently trading at $2.0581, down $0.3419 or 14.2458%, on the Nasdaq.

In an SEC filing, Marinus Pharmaceuticals announced its plans to offer indeterminate number of common stock, preferred stock, debt securities and warrants from time to time, which together shall have an aggregate initial offering price not to exceed $250 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT